glp-1 activity decline
Stop Pretending Obesity Treatment Deters Activity
Stop Pretending Obesity Treatment Deters Activity A surprising 35% of new GLP-1 users report a noticeable drop in physical activity, a trend clinicians often dismiss as normal. The decline is linked to drug-induced changes in brain reward pathways and persistent fatigue, which can undermine the benefits of weight loss. Medical